Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00107913
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2005-04-11
Brief Title:
Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura
Sponsor:
Hematology and Oncology Specialists
Organization:
Hematology and Oncology Specialists
Organization Data
Organization:
Hematology and Oncology Specialists
Class:
OTHER
Study ID:
HOS1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hematology and Oncology Specialists
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None